PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer
MDT is a very effective treatment modality for prostate cancer bone oligometastases and lesion response to MDT can be assessed using the (semi-)quantitative parameters SUV<sub>max</sub> and PSMA-positive lesion volume with established SUV cut-offs.
Authors
- Lena M. Unterrainer
- Freba Grawe (ORCID: https://orcid.org/0009-0002-8259-7359)
- Claus Belka (ORCID: https://orcid.org/0000-0002-1287-7825)
- Nina-Sophie Schmidt-Hegemann (ORCID: https://orcid.org/0000-0002-2091-3603)
- Matthias Brendel (ORCID: https://orcid.org/0000-0002-9247-2843)
- Adrien Holzgreve (ORCID: https://orcid.org/0000-0002-9566-8438)
- Gabriel T. Sheikh (ORCID: https://orcid.org/0000-0002-7026-9203)
- Marcus Unterrainer (ORCID: https://orcid.org/0000-0002-8238-1198)
- Christian Georg Stief (ORCID: https://orcid.org/0000-0003-3291-9460)
- Wolfgang G. Kunz (ORCID: https://orcid.org/0000-0002-5021-1952)
- Paul Rogowski (ORCID: https://orcid.org/0000-0003-3351-8896)
- Alexander Büchner (ORCID: https://orcid.org/0000-0001-7895-7070)
- Minglun Li (ORCID: https://orcid.org/0000-0002-7312-8350)
- Christian Trapp (ORCID: https://orcid.org/0000-0002-5382-5933)
- Clemens C. Cyran (ORCID: https://orcid.org/0000-0001-5630-6242)
- Astrid Delker
- Mathias J. Zacherl
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- LMU Klinikum (DE)
- Molecular Theranostics (United States) (US)
- University Medical Centre Mannheim (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- EJNMMI Reports
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1186/s41824-024-00212-w
- Citations
- 3
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- Chinesisch-Deutsche Zentrum für Wissenschaftsförderung